Back to search

Netherlands· NL-842d1f603609

Urografin 30%, oplossing voor infusie

A diatrizoic acid product containing jodium (moleculair) + meglumineamidotrizoaat + natriumamidotrizoaat 0-water, registered in Netherlands by Bayer B.V.. The same ATC class is registered in 9 of our 19 countries.

ATC V08AA01

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedUrografin 30%, oplossing voor infusieATCV08AA01REGISTER NO.NL-842d1f603609PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Diatrizoic acid is registered in 9 of 19 countries.

Countries holding a registration under ATC V08AA01 (diatrizoic acid), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 5 of them publish a price we can compare per daily dose

Diatrizoic acid · ATC V08AA01

9 / 19 countries

  • Belgiumprice
  • Canada
  • Finlandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
JODIUM (MOLECULAIR) + MEGLUMINEAMIDOTRIZOAAT + NATRIUMAMIDOTRIZOAAT 0-WATER
Manufacturer
Bayer B.V.
Country
Netherlands (NL)
ATC code
V08AA01
ATC class
Diatrizoic acid
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    20077

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ae3939c9-b1b2-4ace-89a2-034275382053
GET /v1/drugs/ae3939c9-b1b2-4ace-89a2-034275382053?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor infusie",
  "route": "Intraveneus gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h20077_smpc.pdf",
  "strength": null,
  "atc_label": "Diatrizoic Acid",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg20077",
  "excipients": [
    "DINATRIUMCALCIUMEDETAAT, GEHYDRATEERD (E 385)",
    "WATER, GEZUIVERD"
  ],
  "substances": [
    "JODIUM (MOLECULAIR)",
    "MEGLUMINEAMIDOTRIZOAAT",
    "NATRIUMAMIDOTRIZOAAT 0-WATER"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h20077.pdf",
  "authorised_at": "1990/05/20",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "20077",
  "additional_monitoring": "N"
}

See everything about diatrizoic acid.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.